| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.073 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |